Form D · Other
Yongye Biotechnology International, Inc.
Beijing, F4 · CIK 0001398551
Offering snapshot reported May 12, 2009 · SEC filing
- Reported sold
- $8.98M Offering amount: $8.98M
- Investors reported
- Not reported Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Not reported As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 12, 2009 | Initial | $8,984,488 | No comparison | Not reported | SEC filing |
| May 1, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- Not reported
- Finders' fees
- Not reported
- Form D file number
- 021-117884
Source: Form D, filed May 12, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Gilmore Larry | Executive |
| Zhang Rijun | Director |
| Sean Shao | Director |
| Sun Taoran | Director, Executive |
| Zishen Wu | Director, Executive |
| Guo Xiaochuan | Director |
| Li Xindan | Director |
| Sam Yu | Executive |
Issuer details
Industry: Other (See others in industry)
Address:
6h Floor, Suite 608 Xue Yuan Intl Tower No. 1 Zhichun Road, Haidian District
Beijing, F4, 100083
Beijing, F4, 100083